These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18177637)

  • 1. Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?
    Beyer CE; Cremers TI
    Eur J Pharmacol; 2008 Feb; 580(3):350-4. PubMed ID: 18177637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE; Boikess S; Luo B; Dawson LA
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.
    Dawson LA; Nguyen HQ
    Eur J Pharmacol; 1998 Mar; 345(1):41-6. PubMed ID: 9593592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
    J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA; Li P
    J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM; Kang TB; Hjorth S; Auerbach SB
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
    Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M
    Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM; Perry KW; Wong DT
    Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study.
    Malagié I; Trillat AC; Douvier E; Anmella MC; Dessalles MC; Jacquot C; Gardier AM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):785-90. PubMed ID: 8971740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A; Rivet JM; Cistarelli L; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists.
    Trillat AC; Malagié I; Mathe-Allainmat M; Anmella MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Sep; 357(2-3):179-84. PubMed ID: 9797034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
    Castro E; Tordera RM; Hughes ZA; Pei Q; Sharp T
    J Neurochem; 2003 Jun; 85(6):1480-7. PubMed ID: 12787067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.